New Targeted Therapy Shows Promising Early Results in Advanced Pancreatic Cancer

Дата публикации: 02-07-2026 14:07:00

An investigational targeted therapy designed to block one of the most common genetic drivers of pancreatic cancer has shown promising early results when combined with standard first-line chemotherapy, according to research presented today at the ESMO Gastrointestinal Cancers Congress 2026

Основное содержимое страницы с новостью.

Схожие новости

#	Наименование новости	Тональность	Информативность	Дата публикации
1	New targeted therapy shows promising early results in advanced pancreatic cancer	2	7	05-07-2026
2	Scientists finally crack an “undruggable” pancreatic cancer target and nearly double survival	0	7.13	04-06-2026
3	Investigators report promising results from Phase II trial of targeted therapy for rare bile duct cancer	7	8	01-07-2026
4	Revolution Medicines Presents Phase 1/2 Clinical Data for Zoldonrasib Combination Regimens in Patients with RAS G12D Metastatic Pancreatic Cancer	0	15.81	02-07-2026
5	Phoenix doctor testing new pancreatic cancer drug shown to potentially double patient survival rates	0	5.82	29-04-2026
6	Lilly's Olomorasib Receives U.S. FDA's Breakthrough Therapy Designation for the Treatment of Previously Treated KRAS G12C-Mutant Advanced Pancreatic Cancer	0	9.33	03-08-2026
7	Scientists turn probiotic bacteria into tiny drug factories for pancreatic cancer	0	10.79	19-08-2026
8	Scientists discover an unexpected way to make pancreatic cancer cells self-destruct	0	11.09	29-06-2026
9	Scientists May Have Found a Cure for Pancreatic Cancer	0	7.46	30-01-2026
10	EMA Recommends Extension of Therapeutic Indications for Enfortumab Vedotin	0	5	19-06-2026

Классификация: Пресс-релизы. Схожих патентов: 0. Схожих новостей: 10. Тональность: 5. Информативность: 7. Источник: www.esmo.org.